Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanical Thrombectomy for Unknown-Onset or Low-ASPECTS Stroke Based on DWI-FLAIR Mismatch (WAKE-IN)
2024-515062-13-00Phase 3Authorised
- Sponsor
- Medical University of Gdańsk
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of aspirin in ischemic stroke (2 arms), sponsored by Medical University of Gdańsk. Primary endpoints: Functional independence at 90 days and Change in ischemic lesion volume on DWI and FLAIR. Planned start Dec 2024; status: authorised.
02
Drugs
aspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2024-515062-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515062-13-00.